Showing 1-1 of 1 result
Scott Kachlany Ph.D.
Funded: 07-01-2012 through 06-30-2014
Funding Type: Research Grant
Institution Location: Newark, NJ
Institution: University of Medicine and Dentistry of New Jersey

Acute lymphocytic leukemia (ALL) is the most common form of childhood cancer, with about 3,000 new cases in the U.S. per year. The leukemia cells in a patient can become resistant to the drugs used to treat disease, which results in a poor outlook for these children. This study tests a new therapeutic agent (Leukothera®) that specifically eliminates leukemia cells for the treatment of children with ALL.